Johnson & Johnson introduces nasal spray for depression

November 30, 2022

FDA Gives Green Light to Agepha Pharma’s Heart Disease Drug

June 20, 2023

Vicebio Raises $100 Million in Series B Funding to Advance RSV Combination Vaccine Through Phase I

September 26, 2024

Must Read

Hansa Biopharma Reports Phase III Success for Imlifidase in Kidney Transplant Patients

September 29, 2025

Crinetics Gets FDA Green Light For Oral Acromegaly Medicine Palsonify

September 29, 2025

Eli Lilly Ends One Bimagrumab Trial in Obesity Patients with Diabetes

September 29, 2025

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Pfizer to Withdraw Vyndaqel in the U.S. Before Patent Expiration in 2028

Roche Ends Development of Obesity Candidate CT-173 and Discontinues Multiple Early-Stage Programs

$20 Million Pediatric CRISPR Center Launched to Develop Treatments for Rare Genetic Diseases

Scientists Identify New Target to Prevent Cancer from Spreading to Bones

Hansa Biopharma Reports Phase III Success for Imlifidase in Kidney Transplant Patients

Eli Lilly Ends One Bimagrumab Trial in Obesity Patients with Diabetes

Moderna Reports Strong Immunological Response From Next-Generation COVID-19 Vaccine mNEXSPIKE Against Emerging Strain

Roche Reports Positive Phase 3 Results for Breast Cancer Drug Giredestrant

Bristol Myers Squibb to Launch Schizophrenia Drug Cobenfy in UK at US Price

Pfizer agrees to a $4.9 billion upfront purchase of Metsera to strengthen obesity portfolio

VectorY Secures Option to Evaluate Shape Therapeutics’ Brain-Penetrating Gene Therapy Technology

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

J&J MedTech presents the first Ottava surgical robot clinical cases

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

Reg impact assessment next in GenAI’s sights, experts claim

The now-urgent automation agenda: out-of-control regulatory workloads necessitate AI adoption

Improving life science R&D outcomes with AI

The medical device sector’s surging regulatory burden: how are suppliers coping?

Regulatory

Crinetics Gets FDA Green Light For Oral Acromegaly Medicine Palsonify

FDA Brings Dormant Drug to Life as Possible Autism Treatment

CHMP Issues Series of Positive Drug Recommendations Across Multiple Indications

FDA Under Trump Reduces Use of Advisory Committees in Drug Approvals

FDA Requests Withdrawal of Intercept’s Ocaliva from U.S. Market

FDA Approves Inlexzo, Johnson & Johnson’s Breakthrough Bladder Cancer Therapy

Editor Picks

Johnson & Johnson introduces nasal spray for depression

FDA Gives Green Light to Agepha Pharma’s Heart Disease Drug

Vicebio Raises $100 Million in Series B Funding to Advance RSV Combination Vaccine Through Phase I

Must Read

Hansa Biopharma Reports Phase III Success for Imlifidase in Kidney Transplant Patients

Crinetics Gets FDA Green Light For Oral Acromegaly Medicine Palsonify

Eli Lilly Ends One Bimagrumab Trial in Obesity Patients with Diabetes

Hot Topics

About Us

Follow Us